Clinical Conductor CTMS?s parent company, Bio-Optronics, Inc., and the Society of Clinical Research Sites (SCRS) have collaborated to expand and advance the knowledge of clinical trial site management challenges and opportunities.
Clinical Conductor CTMS’s parent company, Bio-Optronics, Inc., and the Society of Clinical Research Sites (SCRS) have collaborated to expand and advance the knowledge of clinical trial site management challenges and opportunities. Through this relationship, Clinical Conductor CTMS and the SCRS have identified critical metrics with the aim of establishing industry benchmarks for clinical research sites.
“SCRS is committed to supporting the success of the global clinical site community. Reliable data and metrics provide sites and industry stakeholders with information that will help shape the site landscape,” says Christine Pierre, President of SCRS. “The collaboration with Clinical Conductor CTMS during these early stages has been instrumental in helping us achieve this goal. Their willingness to collaborate with SCRS and to build SCRS’ Site Metrics Platform to allow all sites to contribute their data moving forward is a testimonial to the collaborative efforts SCRS values.”
Clinical Conductor CTMS has provided the SCRS with de-identified, non-patient information from sites who have agreed to participate. Site metrics provided from Clinical Conductor CTMS will assist SCRS to establish site metrics and cycle times for a number of clinical trial parameters. This information includes study startup cycle time, patient enrollment metrics, budgetary and contract statistics and other analytics.
“The advancement of clinical trial management and research operations is one of the guiding principles behind Clinical Conductor CTMS,” explains Dan Kerpelman, CEO of Bio-Optronics. “Working with the SCRS to establish actionable metrics for the benefit of all researchers was a natural initiative for our organization. We take pride in our ability to participate in this noteworthy and beneficial venture.”
The SCRS and Clinical Conductor CTMS collaboration is intended to be an ongoing endeavor and will continue to expand and enhance the industry benchmark initiative that is being established. The initial results include Clinical Conductor CTMS sites that have chosen to participate in this endeavor. However, the SCRS benchmarking engine, built by Clinical Conductor CTMS, has been designed to allow research sites using other CTMS applications to include their data and benefit from future benchmarking reports. The initial results of this collaboration will be unveiled during the “Benchmarking Your Site” session at the Site Solutions Summit in Amelia Island, FL on October 12, 2013.
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.